André Oszwald

509 total citations
38 papers, 290 citations indexed

About

André Oszwald is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, André Oszwald has authored 38 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in André Oszwald's work include Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (9 papers) and Urological Disorders and Treatments (5 papers). André Oszwald is often cited by papers focused on Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (9 papers) and Urological Disorders and Treatments (5 papers). André Oszwald collaborates with scholars based in Austria, France and United States. André Oszwald's co-authors include Ezzat M. Awad, Shafaat Yar Khan, Markus Lipovac, Pavel Uhrín, Johannes M. Breuss, Manuel Mayr, Xiaoke Yin, Hermann Stuppner, Birgit Waltenberger and Éva Compérat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

André Oszwald

31 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Oszwald Austria 8 89 68 61 53 47 38 290
Yini Ke China 13 149 1.7× 63 0.9× 71 1.2× 33 0.6× 63 1.3× 18 409
Phani K. Patibandla United States 8 97 1.1× 58 0.9× 56 0.9× 41 0.8× 42 0.9× 14 349
Nicolle Ceneri United States 6 113 1.3× 47 0.7× 81 1.3× 17 0.3× 67 1.4× 12 282
Trine M. Reine Norway 15 157 1.8× 44 0.6× 59 1.0× 34 0.6× 43 0.9× 22 451
Dajun Hu China 8 79 0.9× 49 0.7× 90 1.5× 48 0.9× 30 0.6× 18 327
Baerbel Lange‐Sperandio Germany 5 170 1.9× 61 0.9× 85 1.4× 26 0.5× 32 0.7× 9 339
Siavash Ghaffari Canada 8 165 1.9× 45 0.7× 62 1.0× 25 0.5× 59 1.3× 14 333
Agnieszka Malińska Poland 12 83 0.9× 43 0.6× 22 0.4× 43 0.8× 107 2.3× 45 334
Jianglei Chen United States 10 157 1.8× 41 0.6× 32 0.5× 31 0.6× 25 0.5× 15 359
Zhicheng Xiao China 8 209 2.3× 51 0.8× 119 2.0× 44 0.8× 69 1.5× 8 434

Countries citing papers authored by André Oszwald

Since Specialization
Citations

This map shows the geographic impact of André Oszwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Oszwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Oszwald more than expected).

Fields of papers citing papers by André Oszwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Oszwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Oszwald. The network helps show where André Oszwald may publish in the future.

Co-authorship network of co-authors of André Oszwald

This figure shows the co-authorship network connecting the top 25 collaborators of André Oszwald. A scholar is included among the top collaborators of André Oszwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Oszwald. André Oszwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kain, Renate & André Oszwald. (2025). Spatial transcriptomics in glomerular diseases. Lara D. Veeken. 64(Supplement_1). i38–i41.
2.
Schachner, Helga, Johannes Kläger, André Oszwald, et al.. (2025). Association of Podometric Findings in Patients With Hypertension and Type 2 Diabetes: A Retrospective Analysis. Hypertension. 82(6). 1071–1080.
3.
Compérat, Éva, et al.. (2024). Cribriform versus Intraductal: How to Determine the Difference. Cancers. 16(11). 2002–2002. 1 indexed citations
4.
Hofmann, G, et al.. (2024). The Histopathology of Leg Ulcers. SHILAP Revista de lepidopterología. 11(1). 62–78. 8 indexed citations
6.
Aigner, Christof, Martina Gaggl, Renate Kain, et al.. (2024). New-Onset Complement-Mediated Thrombotic Microangiopathy during the COVID-19 Pandemic. Kidney & Blood Pressure Research. 49(1). 970–977.
7.
Pirker, Christine, Ursula Lemberger, Reinhard Grausenburger, et al.. (2024). Clofarabine Has a Superior Therapeutic Window as compared to Gemcitabine in Preclinical Bladder Cancer Models. European Urology Oncology. 7(6). 1166–1170.
8.
Kläger, Johannes, et al.. (2024). A single-center retrospective comparison of pT1 substaging methods in bladder cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(4). 817–826. 2 indexed citations
9.
Awad, Ezzat M., Simon Heß, André Oszwald, et al.. (2023). Lipophilic Statins Eliminate Senescent Endothelial Cells by inducing Anoikis-Related Cell Death. Cells. 12(24). 2836–2836. 12 indexed citations
10.
Kläger, Johannes, et al.. (2023). The Prostate Is Not a Pill and Therefore Has No Capsule. SHILAP Revista de lepidopterología. 2(3). 253–260. 1 indexed citations
11.
Schaefer, Anne‐Kristin, Attila Kiss, André Oszwald, et al.. (2022). Single Donor Infusion of S-Nitroso-Human-Serum-Albumin Attenuates Cardiac Isograft Fibrosis and Preserves Myocardial Micro-RNA-126-3p in a Murine Heterotopic Heart Transplant Model. Transplant International. 35. 10057–10057. 4 indexed citations
12.
Fayçal, Chérine Abou, André Oszwald, Miguel Cosenza‐Contreras, et al.. (2022). An adapted passive model of anti-MPO dependent crescentic glomerulonephritis reveals matrix dysregulation and is amenable to modulation by CXCR4 inhibition. Matrix Biology. 106. 12–33. 6 indexed citations
13.
Oszwald, André, et al.. (2022). Digital Spatial Profiling of Glomerular Gene Expression in Pauci-Immune Focal Necrotizing Glomerulonephritis. Kidney360. 4(1). 83–91. 4 indexed citations
15.
Compérat, Éva, et al.. (2021). PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers. World Journal of Urology. 39(11). 4067–4071. 2 indexed citations
16.
Oszwald, André, et al.. (2021). Pathological reporting of cystectomy lymph nodes: a retrospective analysis of experience in Paris. World Journal of Urology. 39(11). 4029–4035. 1 indexed citations
17.
Kornauth, Christoph, Karin Anna Hummel, Helga Schachner, et al.. (2020). ECM Characterization Reveals a Massive Activation of Acute Phase Response during FSGS. International Journal of Molecular Sciences. 21(6). 2095–2095. 14 indexed citations
18.
Compérat, Éva, et al.. (2020). The Genetic Complexity of Prostate Cancer. Genes. 11(12). 1396–1396. 12 indexed citations
19.
Grigorieva, I. V., André Oszwald, Elena Grigorieva, et al.. (2019). A Novel Role for GATA3 in Mesangial Cells in Glomerular Development and Injury. Journal of the American Society of Nephrology. 30(9). 1641–1658. 29 indexed citations
20.
Khan, Shafaat Yar, Ezzat M. Awad, André Oszwald, et al.. (2017). Premature senescence of endothelial cells upon chronic exposure to TNFα can be prevented by N-acetyl cysteine and plumericin. Scientific Reports. 7(1). 39501–39501. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026